The U.S. label guidance on planning a pregnancy depends on the product and why it is used. This study asked how often semaglutide or tirzepatide prescriptions were recorded around delivery [1].
What the study counted
Researchers used TriNetX records for U.S. patients ages 25 to 50 with documented deliveries. They measured whether each person had at least one prescription for either drug in the year before or the year after delivery [1].
In delivery groups from 2019 to 2024, the predelivery rate rose from 0.2 to 6.4 per 1,000 deliveries. The postdelivery rate rose from 0.3 to 14.6 per 1,000. The rates count people with at least one recorded prescription within the relevant window.
What the timing leaves unresolved
The year before delivery can include time before conception. A recorded prescription cannot establish whether someone used the medicine or when they took it.
The study did not compare pregnancy or infant outcomes. The rates show how prescribing changed in these records and cannot establish safety in pregnancy or while breastfeeding.